Clinical trial
Screening Biomarkers for Severe Lupus Based on Multi-omics Studies
NCT05539001 is registered in ClinicalTrials.gov with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening Biomarkers for Severe Lupus Based on Multi-omics Studies
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2023
- Completion date
- June 30, 2025
- Enrollment
- 152 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus